Intellia Therapeutics Head office building

Investors
& Media

Press Releases

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read More

Intellia Therapeutics Announces Third Quarter 2026 Financial Results and Business Updates

Read More

Upcoming
Events

Stock Information

Minimum 15 minutes delayed. Source: LSEG